Brent Egan to Antihypertensive Agents
This is a "connection" page, showing publications Brent Egan has written about Antihypertensive Agents.
Connection Strength
14.137
-
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions. Blood Press. 2022 12; 31(1):164-168.
Score: 0.625
-
Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines. Hypertension. 2022 02; 79(2):338-348.
Score: 0.582
-
Hypertension Control in the United States 2009 to 2018: Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups. Hypertension. 2021 09; 78(3):578-587.
Score: 0.565
-
Antihypertensive Treatment in Elderly Frail Patients: Evidence From a Large Italian Database. Hypertension. 2020 08; 76(2):330-332.
Score: 0.530
-
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019 06; 37(6):1148-1153.
Score: 0.491
-
Adherence in Hypertension. Circ Res. 2019 03 29; 124(7):1124-1140.
Score: 0.485
-
Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol. Hypertension. 2018 12; 72(6):1320-1327.
Score: 0.474
-
Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment. Hypertension. 2018 11; 72(5):1090-1092.
Score: 0.471
-
Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012. Hypertension. 2017 08; 70(2):275-284.
Score: 0.428
-
Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines. Hypertension. 2016 08; 68(2):318-23.
Score: 0.401
-
Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension. J Clin Hypertens (Greenwich). 2016 08; 18(8):817-24.
Score: 0.390
-
Treatment Resistant Hypertension. Ethn Dis. 2015 Nov 05; 25(4):495-8.
Score: 0.383
-
Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacks. J Clin Hypertens (Greenwich). 2015 Apr; 17(4):252-9.
Score: 0.366
-
The growing gap in hypertension control between insured and uninsured adults: National Health and Nutrition Examination Survey 1988 to 2010. Hypertension. 2014 Nov; 64(5):997-1004.
Score: 0.353
-
Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation. 2014 May 20; 129(20):2052-61.
Score: 0.344
-
Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity. Hypertension. 2014 Mar; 63(3):e17-8.
Score: 0.341
-
Pre-hypertension: rationale for pharmacotherapy. Curr Hypertens Rep. 2013 Dec; 15(6):669-75.
Score: 0.335
-
Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013 Oct; 62(4):691-7.
Score: 0.328
-
Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension. J Am Soc Hypertens. 2013 Jan-Feb; 7(1):95-101.
Score: 0.315
-
Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012 Jun; 59(6):1124-31.
Score: 0.301
-
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug 30; 124(9):1046-58.
Score: 0.285
-
Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets? Curr Opin Cardiol. 2011 Jul; 26(4):300-7.
Score: 0.283
-
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010 May 26; 303(20):2043-50.
Score: 0.263
-
Antihypertensive medication prescribing patterns in a university teaching hospital. J Clin Hypertens (Greenwich). 2010 Apr; 12(4):246-52.
Score: 0.260
-
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009 Jul; 22(7):792-801.
Score: 0.243
-
Fixed-dose combinations and hypertension control in community-based practices: application of the "keep-it-simple" principle. Hypertension. 2009 Apr; 53(4):598-9.
Score: 0.241
-
From TROPHY with pride. Am J Hypertens. 2007 Mar; 20(3):342-3; author reply 343-5.
Score: 0.210
-
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006 Mar; 47(3):345-51.
Score: 0.194
-
Challenges and risks in attaining the systolic blood pressure goal of <130 mm Hg in all diabetic patients. J Clin Hypertens (Greenwich). 2006 Jan; 8(1):50-2.
Score: 0.194
-
Gender- and age-related differences in treatment and control of cardiovascular risk factors among high-risk patients with angina. J Clin Hypertens (Greenwich). 2005 Jul; 7(7):386-94.
Score: 0.187
-
Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL. Curr Med Res Opin. 2004 Dec; 20(12):1909-17.
Score: 0.180
-
A systematic approach to managing hypertension and the metabolic syndrome in primary care. South Med J. 2004 Oct; 97(10):932-8.
Score: 0.178
-
An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):26-31; quiz 32-3.
Score: 0.169
-
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension. Blood Press. 2023 Dec; 32(1):1-3.
Score: 0.168
-
Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003 Mar 24; 163(6):681-7.
Score: 0.160
-
Association of Baseline Adherence to Antihypertensive Medications With Adherence After Shelter-in-Place Guidance for COVID-19 Among US Adults. JAMA Netw Open. 2022 12 01; 5(12):e2247787.
Score: 0.156
-
Blood Pressure Control Among Non-Hispanic Black Adults Is Lower Than Non-Hispanic White Adults Despite Similar Treatment With Antihypertensive Medication: NHANES 2013-2018. Am J Hypertens. 2022 Jun 16; 35(6):514-525.
Score: 0.151
-
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. 2022 01; 79(1):e1-e14.
Score: 0.144
-
Optimal Systolic Blood Pressure Target in Resistant Hypertension. Am J Med. 2019 07; 132(7):e623.
Score: 0.123
-
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018 11; 72(5):e53-e90.
Score: 0.118
-
Insights on ?-blockers for the treatment of hypertension: A survey of health care practitioners. J Clin Hypertens (Greenwich). 2018 10; 20(10):1464-1472.
Score: 0.117
-
Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results. J Clin Hypertens (Greenwich). 2018 01; 20(1):79-87.
Score: 0.111
-
Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015 May; 8(3):235-43.
Score: 0.092
-
Prehypertension--prevalence, health risks, and management strategies. Nat Rev Cardiol. 2015 May; 12(5):289-300.
Score: 0.091
-
Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation. 2014 Nov 04; 130(19):1692-9.
Score: 0.089
-
Antihypertensive medication persistence 1-year post-stroke hospitalization. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):869-74.
Score: 0.089
-
The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol. 2014 Aug; 29(8):1403-9.
Score: 0.085
-
Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals. J Clin Hypertens (Greenwich). 2013 Mar; 15(3):154-61.
Score: 0.079
-
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? J Clin Hypertens (Greenwich). 2012 Jul; 14(7):415-21.
Score: 0.075
-
Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9.
Score: 0.068
-
Prehypertension: an opportunity for a new public health paradigm. Cardiol Clin. 2010 Nov; 28(4):561-9.
Score: 0.068
-
Prevalence and management of hypertension in the inpatient setting: a systematic review. J Hosp Med. 2011 Sep; 6(7):417-22.
Score: 0.066
-
Prehypertension: risk stratification and management considerations. Curr Hypertens Rep. 2008 Oct; 10(5):359-66.
Score: 0.059
-
Prehypertension: should we be treating with pharmacologic therapy? Ther Adv Cardiovasc Dis. 2008 Aug; 2(4):305-14.
Score: 0.058
-
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
Score: 0.056
-
Dietary salt restriction and blood pressure in clinical trials. Curr Hypertens Rep. 2007 Aug; 9(4):314-9.
Score: 0.054
-
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006 Apr 20; 354(16):1685-97.
Score: 0.049
-
Ethnic differences in older americans: awareness, knowledge, and beliefs about hypertension. Am J Hypertens. 2005 Jul; 18(7):972-9.
Score: 0.047
-
Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis. 2005; 15(1):11-6.
Score: 0.045
-
Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients. Ethn Dis. 2005; 15(1):25-32.
Score: 0.045
-
Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens. 2004 Jun; 17(6):477-82.
Score: 0.043
-
A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25.
Score: 0.042
-
Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy. Blood Press. 2022 12; 31(1):125-128.
Score: 0.039
-
Associations between birth weight and antihypertensive medication in black and white medicaid recipients. Hypertension. 2002 Jan; 39(1):179-83.
Score: 0.037
-
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens. 1997 Jan; 10(1):68-76.
Score: 0.026
-
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):731-8.
Score: 0.018
-
Measuring the impact of a continuing medical education program on patient blood pressure. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):517-22.
Score: 0.017
-
Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension? Am J Cardiol. 2006 Oct 15; 98(8):1122.
Score: 0.013
-
Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study. Am J Hypertens. 2005 Jul; 18(7):980-5.
Score: 0.012
-
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Am J Med Sci. 2005 Jun; 329(6):292-305.
Score: 0.012
-
Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Am J Med Sci. 1999 Dec; 318(6):357-64.
Score: 0.008
-
Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension. 1996 Jul; 28(1):120-6.
Score: 0.006
-
Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med. 1990 Feb 15; 112(4):270-7.
Score: 0.004
-
Decreased venous distensibility and reduced renin responsiveness in hypertension. Hypertension. 1986 Jun; 8(6 Pt 2):II36-43.
Score: 0.003